Gunnar Wahlberg
Corporate Officer/Principal at IDL BIOTECH AB
Gunnar Wahlberg active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IDL BIOTECH AB | Corporate Officer/Principal | - | - |
| Chief Executive Officer | - | - | |
| Sales & Marketing | 2018-12-31 | - | |
| AROCELL AB | Sales & Marketing | 2020-12-31 | - |
Career history of Gunnar Wahlberg
Statistics
International
| Sweden | 3 |
Operational
| Sales & Marketing | 2 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AROCELL AB | Health Technology |
| Private companies | 1 |
|---|---|
IDL Biotech AB
 IDL Biotech AB Medical SpecialtiesHealth Technology IDL Biotech AB engages in the development, production and marketing of in vitro diagnostic tests for the healthcare sector. The firm is active in the fields of Oncology and Bacteriology, manufacturing various tumor markers and a rapid Salmonella Typhoid test. Its products include TPS, TPAcyk, UBC, Monototal, and Tubex. The company was founded in 1988 and is headquartered in Bromma, Sweden. | Health Technology |
- Stock Market
- Insiders
- Gunnar Wahlberg
- Experience
